Related Experiment Video
Updated: May 10, 2026

09:19
Contrast Enhanced Ultrasound Imaging for Assessment of Spinal Cord Blood Flow in Experimental Spinal Cord Injury
Published on: May 7, 2015
14.5K
Clinical Studies Examining Intrathecal Drainage for Acute Traumatic Spinal Cord Injury: A Living Systematic Review
Linda Papa1, Emily Errante2, Ericka Schaeffer2
1Department of Emergency Medicine, Orlando Regional Medical Center, Orlando, Florida, USA.
Neurotrauma Reports
|October 24, 2025
Summary
Intrathecal cerebrospinal fluid (CSF) drainage via lumbar catheter appears safe and feasible for acute traumatic spinal cord injury (TSCI). This method may improve spinal cord perfusion and neurological recovery, warranting larger trials.
Area of Science:
- Neurosurgery
- Neurology
- Critical Care Medicine
Background:
- Traumatic spinal cord injury (TSCI) leads to significant disability.
- Lumbar cerebrospinal fluid (CSF) drainage is standard for aortic aneurysm surgery but understudied in acute TSCI.
- Intrathecal CSF drainage aims to reduce intrathecal pressure (ITP) and improve outcomes in TSCI.
Purpose of the Study:
- To evaluate the safety and feasibility of intrathecal CSF drainage in acute TSCI.
- To assess the impact of CSF drainage on clinical indices and neurological recovery.
- To identify the need for further research in managing acute TSCI.
Main Methods:
- Living systematic review of literature from database inception to March 2024.
- Included 2 randomized controlled studies and 1 cohort study.
- Analyzed data on CSF drainage techniques, intrathecal pressure (ITP) management, and patient outcomes.
Main Results:
- Intrathecal CSF drainage was demonstrated as feasible and safe in three small studies (11-22 patients).
- Drainage occurred 10-72 hours post-injury with varying ITP targets (<10 mmHg).
- Observed improvements in spinal cord perfusion and trends toward better neurological recovery.
Conclusions:
- Intrathecal CSF drainage is a safe and feasible intervention in the acute phase of TSCI.
- Evidence suggests potential benefits for spinal cord perfusion and neurological outcomes.
- Larger prospective trials are crucial to confirm efficacy and optimize multimodal treatment strategies for TSCI.

